Advertisement

Hepatic abscess as a complication of duodenal-jejunal bypass sleeve system and review of the literature

Published:February 23, 2016DOI:https://doi.org/10.1016/j.soard.2016.02.018
      The obesity epidemic is steadily increasing worldwide, and high body mass index (BMI) is a major risk factor for cardiovascular diseases, diabetes, hypertension, musculoskeletal disorders, and also some cancers [

      World Health Organization. Obesity and overweight. 2015. [cited 2016 March 21]. Available from: 〈http://www.who.int/mediacentre/factsheets/fs311/en/〉.

      ]. Diets are generally unsuccessful [
      • Schouten R.
      • Rijs C.S.
      • Bouvy N.D.
      • et al.
      A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
      ]. Bariatric surgery is today the main treatment for severe obesity [
      • Patel S.R.
      • Hakim D.
      • Mason J.
      • Hakim N.
      The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
      ]. There is a strong interest in finding less invasive methods [
      • Koehestanie P.
      • Betzel B.
      • Dogan K.
      • et al.
      The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation.
      ] and whether that preoperative weight loss improves surgery outcomes [
      • Schouten R.
      • Rijs C.S.
      • Bouvy N.D.
      • et al.
      A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
      ] and reduces perioperative complications [
      • Gersin K.S.
      • Rothstein R.I.
      • Rosenthal R.J.
      • et al.
      Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. World Health Organization. Obesity and overweight. 2015. [cited 2016 March 21]. Available from: 〈http://www.who.int/mediacentre/factsheets/fs311/en/〉.

        • Schouten R.
        • Rijs C.S.
        • Bouvy N.D.
        • et al.
        A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
        Ann Surg. 2010; 251: 236-243
        • Patel S.R.
        • Hakim D.
        • Mason J.
        • Hakim N.
        The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
        Surg Obes Relat Dis. 2013; 9: 482-484
        • Koehestanie P.
        • Betzel B.
        • Dogan K.
        • et al.
        The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation.
        Surg Endosc. 2014; 28: 325-330
        • Gersin K.S.
        • Rothstein R.I.
        • Rosenthal R.J.
        • et al.
        Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
        Gastrointest Endosc. 2010; 71: 976-982
        • Gersin K.S.
        • Keller J.E.
        • Stefanidis D.
        • et al.
        Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity.
        Surg Innov. 2007; 14: 275-278
        • Rodriguez L.
        • Reyes E.
        • Fagalde P.
        • et al.
        Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes.
        Diabetes Technol Ther. 2009; 11: 725-732
        • Levine A.
        • Ramos A.
        • Escalona A.
        • et al.
        Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes.
        Surg Obes Relat Dis. 2009; 5: 371-374
        • Rohde U.
        • Hedback N.
        • Gluud L.L.
        • Vilsboll T.
        • Knop F.K.
        Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies.
        BMJ Open. 2013; 3: e003417
        • Rodriguez-Grunert L.
        • Galvao Neto M.P.
        • Alamo M.
        • Ramos A.C.
        • Baez P.B.
        • Tarnoff M.
        First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.
        Surg Obes Relat Dis. 2008; 4: 55-59
        • Lassle C.
        • Laubner K.
        • Schwacha H.
        • et al.
        Minimally invasive treatment of a duodenal perforation associated with the EndoBarrier duodenal-jejunal bypass liner.
        Endosc. 2014; 46: E171-E172
        • Tarnoff M.
        • Rodriguez L.
        • Escalona A.
        • et al.
        Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.
        Surg Endosc. 2009; 23: 650-656
        • Escalona A.
        • Pimentel F.
        • Sharp A.
        • et al.
        Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
        Ann Surg. 2012; 255: 1080-1085
      2. ENDO Trial Placed on Enrollment Hold. GI Dynamics. March 5, 2015 [cited 2016 Apr 29]. Available from: 〈http://www.gidynamics.com/media-press-release.php?id=139〉.